Blog Archives

New ‘Broad-Spectrum’ Antiviral

Although a variety of broad-spectrum antibiotics have been developed, broad-spectrum antiviral agents have proved more difficult to identify. Effective treatments have been developed for individual viruses such as HIV, herpes viruses and influenza viruses – and vaccines have also been

Tagged with: , ,
Posted in News

Natural Antiviral Proteins Discovered

Viruses are economical with their own genetic information, relying on requisition of host cellular proteins to complete their lifecycle. In a study to identify cellular proteins required by the H1N1 influenza virus, collaborators from Howard Hughes Medical Institute, Harvard Medical

Tagged with: , ,
Posted in News

siRNA Experiments Identify Ebola Virus Drug Targets

Antiviral drugs that exclusively target viral factors rather than host cell processes offer the possibility of fewer side effects but at the cost of limiting possible targets and of providing selective pressure for the generation of drug-resistant viral variants. Recent

Tagged with: , ,
Posted in News

‘Shock and Kill’ Tactics to Eradicate HIV-1

Although highly active antiretroviral therapy (HAART) has proved effective at controlling HIV-1 replication, eradication of the virus from an infected individual cannot be achieved with current treatments. Latently infected, resting memory CD4+ T-cells and macrophages act as reservoirs for the

Tagged with: ,
Posted in News

Candidate Drug for Henipavirus Infection

Two viruses from the Henipavirus genus, Nipah (NiV) and Hendra (HeV), are recently emerged zoonitic (transmissible from animals to humans) paramyxoviruses that cause encephalitis in humans. HeV, previously known as equine morbillivirus, emerged as the causative agent of an outbreak

Tagged with: ,
Posted in News

Cyclophilin Inhibitors for the Treatment of HCV

Infection with hepatitis C virus (HCV) is a major cause of acute hepatitis and chronic liver disease, including cirrhosis and cancer. Current treatments are not able to cure all of those chronically infected with the virus, and there is a

Tagged with: ,
Posted in News

SARS Protease Inhibitor Identified

The first cases of severe acute respiratory syndrome (SARS), which is caused by the SARS coronavirus (SARS-CoV), are thought to have occurred in Guangdong province in southern China in November 2002. The virus quickly spread around the globe, with the

Tagged with: ,
Posted in News

New Target for Hepatitis C Treatment

Over 150 million people are estimated to be infected with the Hepatitis C virus. During the early stages of infection, the majority of people are free of symptoms but a significant number will later develop cirrhosis and possibly liver cancer.

Tagged with: ,
Posted in News

Quercetin Reduces Impact of Exercise Stress on Flu Infection in Mice

Whilst moderate exercise in humans appears to enhance immune function and resistance to viral infections, there is evidence that exhausting exercise suppresses the immune response and increases susceptibility to infections. Intense exercise stress has also been shown to increase susceptibility

Tagged with: ,
Posted in News

Cell Receptor for HCMV Entry Identified

Human Cytomegalovirus (HCMV) is a member of the Herpes virus family and infects 50-80% of adults in the US. After infection, the virus remains latent in the body for the rest of the person’s life. Most people who are infected

Tagged with: , ,
Posted in News